Mechanistic competitive binding interaction study between olmutinib and colchicine with model transport protein using spectroscopic and computer simulation approaches

Author(s):  
Tanveer A. Wani ◽  
Ahmed H. Bakheit ◽  
Seema Zargar ◽  
Salman Alamery
Author(s):  
Suwicha Patnin ◽  
Arthit Makarasen ◽  
Mayuso Kuno ◽  
Sirinya Deeyohe ◽  
Supanna Techasakul ◽  
...  

2009 ◽  
Vol 109 (2) ◽  
pp. 206-216 ◽  
Author(s):  
Jana M. Weiss ◽  
Patrik L. Andersson ◽  
Marja H. Lamoree ◽  
Pim E. G. Leonards ◽  
Stefan P. J. van Leeuwen ◽  
...  

2017 ◽  
Vol 9 ◽  
pp. 102
Author(s):  
Joshita Djajadisastra ◽  
Hamka Decky Purnama ◽  
Arry Yanuar

Objective: A drug can replace other drugs in the same binding position in protein plasma, increasing pharmacological response due to the increasedfree drug concentration. Drug shifting is critical when a compound is tightly bound to a protein. For example, a binding fraction change, from 98% to94%, may increase the free fraction 3 times, from 2% to 6%. Knowing that there is an interaction between mefenamic acid and piroxicam on plasmaprotein, more specifically on human albumin, this study aimed to visualize the interaction between both drugs and human albumin in silico.Methods: This study used AutoDock4 as a molecular docking technique, obtaining binding visualizations, binding energies (ΔG), and inhibitionconstants (Ki) of both mefenamic acid-albumin and piroxicam-albumin bindings.Results: It is shown that the ΔG and Ki of both mefenamic acid and piroxicam are −5.47 kcal/mol (98.59 μM) and −7.46 kcal/mol (3.42 μM), respectively.Conclusions: The process of binding mefenamic acid to albumin can be substituted with piroxicam due to its higher ΔG and Ki values. It can bepredicted that this interaction will increase the free mefenamic acid concentration in blood plasma which, in turn, enhances the therapeutic effect.


RSC Advances ◽  
2015 ◽  
Vol 5 (80) ◽  
pp. 65496-65513 ◽  
Author(s):  
Himank Kumar ◽  
Vinod Devaraji ◽  
Ritika Joshi ◽  
Manojkumar Jadhao ◽  
Piyush Ahirkar ◽  
...  

The usefulness of heterocyclic chalcone derivative as a therapeutic target in controlling hypertension and its site specific binding interaction with model transport protein to get a clear picture about its delivery mechanism.


Luminescence ◽  
2019 ◽  
Vol 34 (6) ◽  
pp. 563-575 ◽  
Author(s):  
Anukul Maji ◽  
Maidul Beg ◽  
Somnath Das ◽  
Nandan Kumar Sahoo ◽  
Pradeep K. Jha ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document